Neuropsychopharmacology
- The spino-parabrachio-amygdaloid pathway is critical for the manifestation of chronic pain2 years ago
- Influence of gut microbiome metabolites on cocaine demand and cocaine-seeking behavior2 years ago
- Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression2 years ago
- The national institute on drug abuse diversity scholars network: success for a diverse addiction science workforce2 years ago
- Leveraging AI to predict substance use disorder treatment outcomes2 years ago
- In Memoriam George K. Aghajanian, M.D. 1932 -20232 years ago
- People who binge drink show neuroendocrine tolerance to alcohol cues that is associated with immediate and future drinking- results from a randomized clinical experiment2 years ago
Journal of Psychopharmacology
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study4 years ago
- Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA4 years ago
- Prospective memory deficits following acute alcohol consumption4 years ago
- Altered amygdala-cortical connectivity in individuals with Cannabis use disorder4 years ago
- Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case series4 years ago
- Effects of 31 recombinant CYP2C19 variants on clomipramine metabolism in vitro4 years ago
- Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial4 years ago
European Neuropsychopharmacology
- Contents3 years ago
- ECNP Calendar of Meetings3 years ago
- Corrigendum to ‘BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression’ European Neuropsychopharmacology Volume 58, May 2022, Pages 103-1083 years ago
- Editorial Board3 years ago
- Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder3 years ago
- Requiem or resurrection: Classic monoamine oxidase inhibitors revisited3 years ago
- A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia3 years ago